Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-2 of 2
Keywords: CCNU
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Ifosfamid versus Ifosfamid + CCNU in der Behandlung des inoperablen kleinzelligen Bronchuskarzinoms: Eine klinische Studie
Available to PurchaseSubject Area:
Oncology
Journal:
Onkologie
Onkologie (1982) 5 (2): 56–59.
Published Online: 21 April 2009
...O. Kokron; M. Micksche; R. Titscher; H. Wrba In einer prospektiven randomisierten Studie wurde an 55 ausgewählten Patienten mit inoperablem kleinzelligem Bronchuskarzinom die Effektivität einer Ifosfamid-Monotherapie mit der Kombination Ifosfamid + CCNU verglichen. Die anfangs mitgeführte, nur...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (1983) 6 (2): 62–65.
Published Online: 21 April 2009
... (ein aromatisches Vitamin-A-Säurederivat) + Bleomycin + CCNU (21 evaluierbare Patienten) versus Bleomycin + CCNU (25 eva-luierbare Patienten). Unabhängig vom histologischen Differenzierungsgrad wurden bei 8 Patienten (17%) Teilremissionen zwischen 25%-49% Tumorrückbildung beobachtet; bei 22 Patienten...